Evolution Devices Announces First Multi-Site Clinical Sale of EvoWalk to Sheltering Arms Institute

Why It Matters

The partnership validates demand for advanced multi‑muscle FES in rehabilitation, accelerating adoption and cost‑efficiency across health systems.

Key Takeaways

• EvoWalk sold to multiple Sheltering Arms locations, first multi‑site deal
• Device stimulates up to six muscle groups, improving natural gait patterns
• AI analytics provide real‑time step count, speed, cadence for clinicians
• Reusable leads eliminate per‑patient electrode expenses, boosting efficiency

Pulse Analysis

Functional electrical stimulation (FES) has long been a cornerstone of neurorehabilitation, yet traditional single‑muscle devices often fall short of restoring a natural gait. EvoWalk advances the field by targeting up to six muscle groups simultaneously, delivering coordinated stimulation that mimics normal walking patterns. Its wearable, below‑knee form factor enables both clinic and home use, while integrated AI continuously records step count, speed, and cadence, giving clinicians a richer data set to fine‑tune therapy.

Beyond the technology, EvoWalk addresses a critical bottleneck in busy rehabilitation centers: setup time. Sheltering Arms Institute reported that the system’s intuitive design reduces equipment configuration from minutes to seconds, freeing therapists to spend more time with patients. Real‑time Bluetooth connectivity streams performance metrics directly to clinicians’ dashboards, supporting data‑driven decision making. Moreover, the reusable leads and electrodes eliminate recurring disposable costs, a significant expense for large health systems scaling advanced neurotechnology.

The multi‑site sale to Sheltering Arms marks a pivotal step from early‑stage innovation to market penetration. By proving the platform’s efficacy and operational efficiency in a leading rehab network, Evolution Devices positions itself for national rollout. The company’s strategy to leverage aggregated patient data for continuous AI improvement could set new standards for personalized mobility care, potentially reshaping the rehabilitation market and expanding access for millions with neurological impairments.